INS and breast cancer: Research has shown that insulin and IGF also supports the development and functioning of cancer stem cells (CSCs), which contributes to tumor growth and metastasis.48 Several preclinical studies have shown that PI3K – AKT – mTOR pathway contributes to endocrine therapy resistance in breast cancer (Figure 3).